2024 Annual Lingeman Weisberger Lectureship

Friday, November 15, 2024, 1:00 PM - 4:30 PM, Hine Hall Tower Ballroom (HO116), Indianapolis, IN


The lectureship is intended to provide otolaryngologists–head and neck surgeons and the general medical community with information on a variety of otolaryngology-related topics, including current research in how predictive AI predictive analytics approaches can be used to enhance patient care.

1. Identify how rapidly evolving machine learning/AI predictive analytics approaches can be used to enhance patient care.
2. Describe the advantages of mentorship for learners and new practitioners.
3. Recognize importance of using the test scenario of decision-making for surgery in chronic rhinosinusitis

This is an in-person event. There will be no virtual option to attend.

Click on the Register tab to pre-register for the course. Pre-registration is open until the end of the day on Friday, Nov. 8. 

Event Location:

University Tower Ballroom
911 W. North Street
Indianapolis, IN 46202

Parking: Validated parking is available in the Tower Garage located at the southwest corner of North Street and Blake Street (875 W. North Street).

 

 

Disclosure Summary
Indiana University School of Medicine (IUSM) policy ensures that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all financial relationships with any ineligible companies so that IUSM may identify and resolve any conflicts of interest prior to the activity. All educational programs sponsored by Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor.

There are no relevant financial relationship(s) with ineligible companies for anyone who was in control of the content of this activity, except:
Dr. Troy Woodard, MD has disclosed consulting fees from Medtronic, Inc., 3D Matrix, Aerin Medical, Neurent, and Regeneron (this relationship has ended).

All of the relevant financial relationships listed for these individuals have been mitigated.

An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or [email protected]. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.

AMA PRA Category 1 Credits™ (2.50 hours), Non-Physician Attendance (2.50 hours)

Mitigation of Relevant Financial Relationships

Indiana University School of Medicine, Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, November 15, 2024